Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C49H55NO14S |
Molecular Weight | 914.024 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]4(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C5=CC=CC=C5)C6=CC=CC=C6)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@H](C[C@H]7OC[C@@]27OC(C)=O)OCSC)C4(C)C
InChI
InChIKey=UBJAHGAUPNGZFF-XOVTVWCYSA-N
InChI=1S/C49H55NO14S/c1-27-33(62-45(57)38(53)37(30-17-11-8-12-18-30)50-43(55)31-19-13-9-14-20-31)24-49(58)42(63-44(56)32-21-15-10-16-22-32)40-47(6,41(54)39(61-28(2)51)36(27)46(49,4)5)34(60-26-65-7)23-35-48(40,25-59-35)64-29(3)52/h8-22,33-35,37-40,42,53,58H,23-26H2,1-7H3,(H,50,55)/t33-,34-,35+,37-,38+,39+,40-,42-,47+,48-,49+/m0/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Preclinical antitumor activity of two novel taxanes. | 2001 |
|
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476. | 2001 Dec 20 |
|
BMS-184476 Bristol-Myers Squibb. | 2003 Jun |
|
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer. | 2005 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15684226
Fifty-six previously treated advanced NSCLC patients received BMS-184476 at a dose of 60 mg/m(2) administered intravenously over 1 h every 21 days.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67437
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
||
|
NCI_THESAURUS |
C1490
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3811W2NBZ8
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY | |||
|
160237-25-2
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY | |||
|
C426424
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY | |||
|
DB12633
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY | |||
|
DTXSID30873340
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY | |||
|
6918461
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY | |||
|
C1843
Created by
admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
|
PRIMARY |
ACTIVE MOIETY